Raiffeisen Bank International AG Takes $31.03 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Raiffeisen Bank International AG purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, HoldingsChannel.com reports. The fund purchased 58,875 shares of the medical equipment provider’s stock, valued at approximately $31,025,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Atala Financial Inc purchased a new position in Intuitive Surgical during the 4th quarter valued at about $25,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the fourth quarter worth $26,000. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth about $28,000. Finally, Hurley Capital LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 0.4%

ISRG stock opened at $565.94 on Thursday. The stock has a market cap of $202.84 billion, a PE ratio of 88.29, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. The firm’s 50-day simple moving average is $502.26 and its 200 day simple moving average is $535.79. Intuitive Surgical, Inc. has a fifty-two week low of $386.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period in the prior year, the company posted $1.50 EPS. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the subject of several recent analyst reports. Evercore ISI lowered their price target on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a report on Wednesday, April 23rd. Truist Financial lowered their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a research note on Monday, April 14th. Royal Bank of Canada lowered their target price on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Finally, Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $598.95.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 188 shares of the business’s stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $566.94, for a total transaction of $106,584.72. Following the completion of the sale, the chief financial officer now owns 7,162 shares in the company, valued at approximately $4,060,424.28. This trade represents a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 32,680 shares of company stock valued at $16,854,345 over the last 90 days. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.